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by controlling the homeostasis of intestinal stem
cells
Stephanie Jaeckel1, Markus Kaller1, Rene Jackstadt1, Ursula Götz1, Susanna Müller2, Sophie Boos3,4,5,
David Horst2,4,5,6, Peter Jung3,4,5 & Heiko Hermeking1,4,5
The gene encoding the transcription factor TFAP4/AP4 represents a direct target of the
c-MYC oncoprotein. Here, we deleted Ap4 in ApcMin mice, a preclinical model of inherited
colorectal cancer. Ap4 deﬁciency extends their average survival by 110 days and decreases
the formation of intestinal adenomas and tumor-derived organoids. The effects of Ap4
deletion are presumably due to the reduced number of functional intestinal stem cells (ISCs)
amenable to adenoma-initiating mutational events. Deletion of Ap4 also decreases the
number of colonic stem cells and increases the number of Paneth cells. Expression proﬁling
revealed that ISC signatures, as well as the Wnt/β-catenin and Notch signaling pathways are
downregulated in Ap4-deﬁcient adenomas and intestinal organoids. AP4-associated sig-
natures are conserved between murine adenomas and human colorectal cancer samples. Our
results establish Ap4 as rate-limiting mediator of adenoma initiation, as well as regulator of
intestinal and colonic stem cell and Paneth cell homeostasis.
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The TFAP4/AP4 protein belongs to the class of basic-helix-loop-helix leucine zipper (bHLH-LZ) transcription factors(reviewed in Jung and Hermeking1). AP4 exclusively forms
homodimers, which bind to the E-box motif CAG/CCTG and
thereby either repress or activate the expression of target genes.
We previously identiﬁed the AP4 gene as a direct transcriptional
target of c-MYC2. AP4 is expressed in progenitor/transient-
amplifying (TA) cells in human colonic crypts, and in colorectal
cancer (CRC) in a pattern similar to c-MYC. The prototypic
oncogene c-MYC is a direct target of the APC (adenomatous
polyposis coli) /Wnt (Wingless/Int-1) pathway3 and an essential
mediator of tumor formation induced by inactivation of Apc in
the intestine4,5. Previous studies performed in CRC cell lines or
mouse embryonic ﬁbroblasts suggested that AP4 may contribute
to the progression of CRC by regulating genes involved in
epithelial–mesenchymal transition (EMT) and proliferation6–8.
However, the organismal function of Ap4 in the intestinal epi-
thelium and its relevance for intestinal tumor formation has so far
not been studied using a genetic approach.
The present study shows that inactivation of Ap4 by deletion
leads to decreased adenoma formation in ApcMin mice, which
represent a preclinical model of familial adenomatous polyposis
(FAP)9,10. mRNA proﬁling revealed downregulation of a large
number of genes involved in Wnt/β-catenin and/or Notch sig-
naling in Ap4-deﬁcient adenomas of ApcMin mice and organoids
derived from the epithelium of the small intestine. In line with
these regulations, Ap4-deﬁcient intestinal organoids and tumor-
oids show impaired re-growth capacities and therefore decreased
stemness. The reduced number of tumors observed in Ap4-deﬁ-
cient mice is presumably due to a decrease in the number of
functional intestinal stem cells (ISCs). In addition, Ap4 inacti-
vation causes an increase in the number of Paneth cells. Our
results establish Ap4 as a regulator of ISC and Paneth cell
homeostasis and as a rate-limiting mediator of intestinal tumor
initiation.
Results
Role of Ap4 in intestinal adenoma formation. Here we deter-
mined the effect of Ap4 deﬁciency on adenoma formation in the
intestine of ApcMin mice, which harbor an inactivating mutation
in one Apc allele. Upon spontaneous loss of the second Apc allele,
these mice develop ~50–100 adenomas in the small intestine by
the age of 4–6 months. As expected, adenomas in ApcMin/+/Ap-/-
mice did not display Ap4 expression, whereas adenomas of
ApcMin mice showed elevated expression of Ap4 (Fig. 1a).
Approximately 50% of ApcMin mice succumbed to intestinal
adenomas by ~180 days of age (Fig. 1b), which was in line with
previous reports11,12. However, in Ap4-deﬁcient ApcMin mice
intestinal cancer-related death was delayed on average by
110 days, with heterozygous mice showing an intermediate delay.
Ap4 deﬁciency was associated with a ~4-fold decrease in the
number of adenomas in the small intestines of moribund ApcMin
mice, while the size of adenomas increased (Fig. 1c–e). Unex-
pectedly, the proliferation rate within small intestinal adenomas
of moribund ApcMin mice was not affected by loss of Ap4 (Sup-
plementary Fig. 1). When adenomas of age-matched, 120 days old
ApcMin mice were compared, the Ap4-deﬁcient mice showed a
~5-fold decrease in the number of adenomas, whereas the size of
the adenomas was not affected (Fig. 2a-c). A decreased number of
tumors was also detected in the colon of Ap4-deﬁcient ApcMin
mice when compared with Ap4-wild-type ApcMin mice (Supple-
mentary Fig. 2a). However, due to the low incidence of adenomas
in the colon of ApcMin mice these differences did not reach sta-
tistical signiﬁcance. The uniform tumor size and the unchanged
proliferation rate of tumors in the small intestine (Supplementary
Fig. 2b) in 120 days old mice suggested that the increase in
adenoma size seen in moribund animals was most likely due to
the increased life-span of Ap4-deﬁcient ApcMin mice. The effects
of Ap4 loss on tumorigenesis observed in ApcMin mice were
independent of the gender (Supplementary Fig. 2c-e). When we
analyzed ApcMin mice with intestinal epithelial cell (IEC)-speciﬁc
deletion of Ap4, which was achieved by crossing Villin-Cre with
Ap4ﬂ/ﬂ mice, we obtained similar results as for ApcMin mice with
germ-line deletion of Ap4: that is, in Ap4ΔIEC/ApcMin mice
intestinal cancer-related death was signiﬁcantly delayed by
110 days, with heterozygous mice showing an intermediate delay
(Supplementary Fig. 2f). Ap4ΔIEC/ApcMin mice showed a sixfold
decrease in the number of adenomas in the small intestines of
moribund and a ﬁvefold decrease in the small intestine of
120 days old ApcMin mice, whereas the size of adenomas increases
in moribund mice and the size of the adenomas was not affected
in 120 days old mice (Supplementary Fig. 2g, h). Epithelial-
speciﬁc deletion of Ap4 in ApcMin mice also resulted in a
decreased number of adenomas in the colon, although this effect
was not statistically signiﬁcant (Supplementary Fig. 2i). Deletion
of Ap4 in epithelial cells did not affect the proliferation rate of
established adenomas of ApcMin mice (Supplementary Fig. 2j).
Therefore, the effects of Ap4 deletion in the germ-line on ade-
noma formation are presumably intestinal epithelial cell auton-
omous. Taken together, these results show that Ap4 is rate
limiting for adenoma initiation in ApcMin mice. As c-Myc is a
required mediator of intestinal tumor formation in Apc-mediated
tumorigenesis, the results imply a pivotal role of Ap4 among the
many known c-Myc target genes in mediating intestinal tumor
formation.
mRNA expression proﬁling of Ap4-deﬁcient adenomas. To
identify pathways mediating the effects of Ap4, we compared the
mRNA expression proﬁles of intestinal adenomas that formed in
ApcMin mice with and without Ap4 deletion. By applying next-
generation sequencing (NGS), we identiﬁed 1459 mRNAs that
were differentially regulated with a fold change in expression > 1.5
(p < 0.05) due to deletion of Ap4 (Fig. 3a). Out of these, 954
mRNAs were signiﬁcantly downregulated, and 505 mRNAs were
upregulated in Ap4-deﬁcient ApcMin mice (Fig. 2b, c). Notably,
pathway analysis showed that mRNAs encoding for proteins
involved in EMT, as well as cell cycle regulatory proteins (e.g.,
E2F targets) were signiﬁcantly enriched among the down-
regulated mRNAs (Supplementary Fig. 3a, Supplementary
Data 1). Furthermore, gene set enrichment analysis (GSEA)
showed that mRNAs characteristic for Lgr5-positive ISCs13 were
preferentially downregulated in Ap4-deﬁcient adenomas (Fig. 4a,
b). We validated this ﬁnding using additional, previously pub-
lished ISC-speciﬁc gene signatures14,15 (Supplementary Fig. 3c,
Supplementary Data 2). These signatures also showed preferential
enrichment among the mRNAs downregulated after deletion of
Ap4. Moreover, mRNAs encoding for proteins involved in Wnt/
β-catenin and Notch signaling, which control the homeostasis of
ISCs16,17, were also preferentially downregulated in Ap4-deﬁcient
adenomas (Fig. 4a, b, Supplementary Fig. 3c, Supplementary
Data 2). Genes downregulated upon deletion of Ap4 included ISC
markers induced by Wnt/β-catenin signaling, such as Lgr5 and
Ascl218–20, or by Notch signaling, such as Olfm421, as well as
additional direct Wnt/β-catenin and/or Notch target genes with
critical functions in the Wnt and Notch signaling pathways, such
as Sox4, Tcf7/Tcf1, Axin2, EphB3, Jag1, Jag2, Hes1 and c-Myc
(Fig. 4b). Furthermore, Notch1 itself was downregulated in Ap4-
deﬁcient adenomas. Taken together, these results imply that Ap4
regulates the homeostasis of ISCs via activating Wnt/β-catenin
and/or Notch signaling pathways.
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Fig. 1 Deletion of Ap4 in ApcMin/+ mice prolongs survival and decreases the frequency of adenomas. a Immunohistochemical detection of Ap4 in
adenomas of moribund ApcMin/+ mice with the indicated genotype. Counterstaining with hematoxylin. Scale bar= 50 µm. b Kaplan–Meier survival analysis
of ApcMin/+ mice with the indicated genotypes. Censored mice without intestinal tumor-related death are indicated on the Kaplan–Meier curve as tick
marks. c Macroscopic pathology of representative polyps in the small intestine (ileum) of moribund ApcMin/+ mice with the indicated genotype, scale in
cm. d Representative sections through rolls of the small intestine stained for hematoxylin and eosin (HE). Scale bar= 500 µm. e Quantiﬁcation of adenoma
number/mouse (left panel) and tumor diameter (right panel) in the intestine of six male and six female (ApcMin/+/Ap4+/+), ﬁve male and ﬁve female
(ApcMin/+/Ap4+/-) or four male and four female (ApcMin/+/Ap4-/-) moribund ApcMin/+ mice. The box plot extends from the 25th to 75th percentiles. The
line in the middle of the box is plotted at the median. The whiskers underneath or above the boxes range from min. to max. value, respectively. b Results
were subjected to a log-rank test with p-values * < 0.05, ** < 0.01, *** < 0.001, n.s. not signiﬁcant. e Results represent the mean ± SD. Results were
subjected to an unpaired, two-tailed Student’s t-test with p-values * < 0.05, ** < 0.01, *** < 0.001, n.s. not signiﬁcant. See also Supplementary Fig. 1
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Recently, Ap4 was shown to maintain a c-Myc-induced
transcriptional program in activated T cells22 and germinal
center B cells23. In line with these ﬁndings, c-Myc target genes
were preferentially downregulated in Ap4-deﬁcient adenomas
(Fig. 4a; Supplementary Data 2). However, the changes in
expression of c-Myc target genes observed after deletion of Ap4
were rather modest compared to the regulations observed in ISC
signature or Notch signaling components (Supplementary
Fig. 3d). Similarly, E2F targets, though signiﬁcantly enriched
among the downregulated RNAs (Supplementary Fig. 3c),
displayed only modest changes in expression that were compar-
able to those of c-Myc targets (Supplementary Fig. 3d). These
modest regulations of c-Myc and E2F targets may explain the
lacking inﬂuence of Ap4 deletion on cell proliferation within
adenomas.
We exemplarily conﬁrmed the differential regulation detected
by NGS using quantitative PCR (qPCR). Thereby, we validated
the downregulation of the stem cell markers Smoc2, Lgr5 and
Olfm4, as well as the repression of several genes involved in the
Wnt/β-catenin signaling and/or Notch signaling in Ap4-deﬁcient
adenomas (Fig. 4c). Consistent with its previously reported
repression by AP42, Cdkn1a/p21 was upregulated in Ap4-
deﬁcient adenomas. Interestingly, we did not detect a change in
mRNA or protein levels of Ctnnb1 (β-catenin) in ApcMin
adenomas (Fig. 4c, Supplementary Fig. 3e), suggesting that Ap4
directly regulates Wnt/β-catenin target genes.
Next, we analyzed whether Ap4 directly regulates the
expression of ISC markers and components of the Wnt/β-catenin
and/or Notch signaling pathways. Our analysis of Ap4 DNA-
binding patterns in murine T and B cells22,23 revealed Ap4
occupancy within the promoter regions of Ascl2, Axin2, c-Myc,
Dll1, Dll4, EphB3, Hes1, Hey1, Jag1, Jag2, Notch1, Sox4, and Tcf7
(Supplementary Fig. 3f). We performed quantitative chromatin-
immunoprecipitation (qChIP) analysis to conﬁrm Ap4 occu-
pancy in the murine CRC cell line CT26 at the promoters of the
following genes: Ascl2, Dll1, Dll4, EphB3, Hes1, Jag1, Jag2, Notch1,
Sox4 and Tcf7 (Fig. 4d). Similar to the promoter of human
CDKN1A/P21, the murine Cdkn1a/p21 promoter also contains
Ap4-binding sites that showed occupancy by Ap4 (Fig. 4d).
Therefore, Cdkn1a/p21 is a conserved, direct Ap4 target. Taken
together, these results suggest that the differential regulation of
genes involved in Wnt/β-catenin and/or Notch signaling
observed in Ap4-deﬁcient ApcMin adenomas is a direct con-
sequence of the absence of Ap4 at the respective promoters.
Analysis of tumor organoids from Ap4-deﬁcient ApcMin mice.
Our NGS results suggested that Ap4 is involved in maintaining a
stem cell-like expression pattern in tumor cells. This was con-
ﬁrmed by in situ hybridization with a probe detecting the mRNA
expression of Lgr5 (Fig. 5a) or Smoc2 (Supplementary Fig. 4a) in
small intestinal adenomas of ApcMin mice. Indeed, Ap4-deﬁcient
adenomas displayed less cells positive for Lgr5 or Smoc2 mRNA
expression when compared with adenomas expressing Ap4.
Therefore, the number of tumor stem cells is presumably
decreased in the absence of Ap4. Next, we generated tumor
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Fig. 2 Ap4 deletion decreases frequency but not size of adenomas in age-matched ApcMin/+ mice. aMacroscopic pathology of representative polyps in the
small intestine (ileum) of 120 days old ApcMin/+ mice with the indicated genotype, scale in cm. b Representative sections through rolls of the small
intestine were stained for β-catenin. Scale bar= 500 µm (upper pictures) or 250 µm (lower pictures). c Quantiﬁcation of adenoma number/mouse (left
panel) and tumor diameter (right panel) in the intestine of four male and four female 120 days old ApcMin/+ mice per genotype. The box extends from the
25th to 75th percentiles. The line in the middle of the box is plotted at the median. The whiskers represent the minimal and maximal values. c Results
represent the mean ± SD. Results were subjected to an unpaired, two-tailed Student’s t-test with p-values * < 0.05, ** < 0.01, *** < 0.001, n.s.: not
signiﬁcant. See also Supplementary Fig. 2
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organoids using single cells derived from adenomas of ApcMin
mice. Indeed, cells directly isolated from Ap4-deﬁcient adenomas
formed tumor organoids ex vivo with a signiﬁcantly lower fre-
quency than those derived from Ap4 wild-type adenomas
(Fig. 5b). However, after the ﬁrst passage ex vivo the Ap4-deﬁ-
cient and -proﬁcient tumoroids re-built new tumor organoids
with a comparable frequency and growth rate (Fig. 5b). There-
fore, Ap4 appears to be required for the initiation, but not for the
maintenance of ex vivo cultured intestinal tumoroids. The dele-
tion of Ap4 in these tumor organoids was accompanied by lower
levels of the ISC markers Smoc2, Lgr5 and Olfm4 when compared
with Ap4 wild-type adenomas (Fig. 5c). Additional genes involved
in Wnt/β-catenin signaling and/or Notch signaling, including
Notch1 itself, were also downregulated in Ap4-deﬁcient tumor
organoids (Fig. 5d). Also at the protein levels, the cleaved, active
form of Notch1 (NICD1) and Hes1, which is encoded by a Notch
target gene, were decreased in Ap4-deﬁcient tumor organoids
indicating a decrease in Notch signaling (Fig. 5e). Therefore, the
reduced de novo tumor organoid formation capacity may be
caused by the downregulation of genes required for in vivo ISC
function upon Ap4 loss.
Subsequently, we isolated small intestinal crypts from Lgr5-
CreERT2/Apcﬂ/ﬂ and Lgr5-CreERT2/Apcﬂ/ﬂ/Ap4ﬂ/ﬂ mice. After
plating of crypts in Matrigel overlaid with ENR media (containing
epidermal growth factor (EGF), Noggin and RSPO1), we acutely
deleted Apc or Apc in combination with Ap4 in Lgr5-positive
stem cells of newly formed intestinal organoids by addition of 4-
hydroxy-tamoxifen (4-OHT). After passaging (passage 1) and
seeding the same amount of cells per drop of Matrigel, we
switched culture conditions to EN media devoid of RSPO1, in
which only Apc-deﬁcient tumoroids can grow. We obtained less
de novo formed tumoroids after Ap4 deletion when compared
with Ap4-proﬁcient tumoroids (Fig. 5f, g). This supports the
notion that Ap4 has an important role during tumor initiation
and conﬁrms the result we previously obtained in vivo. Reassur-
ingly, tumoroids did not form in the absence of RSPO1 and 4-
OHT (Supplementary Fig. 4b). During serial passaging, the
amount and size of tumoroids was not inﬂuenced by the deletion
of Ap4 (Fig. 5f, g, h and Supplementary Fig. 4c). To exclude the
possibility that Ap4-deﬁcient tumoroids grew due to incomplete
deletion of Ap4, the complete deletion of Ap4 was conﬁrmed by
genomic PCR (Supplementary Fig. 4d). Taken together, these
results conﬁrm a critical role of Ap4 in the initiation, but not for
the maintenance of the tumoroids. These results are in line with
the observations initially obtained with ApcMin mice, where Ap4
loss decreased the number of adenomas but not their size.
Ap4 regulates the homeostasis of ISCs. Next, we analyzed the
expression of Ap4 and the effect of Ap4 deletion in the normal,
murine intestine. Ap4 protein was detected at the crypt base and
in TA cells located above the crypt base in the small intestine
(Fig. 6a, left panel). As expected, Ap4 expression was not
detectable in the intestinal epithelia of Ap4 knock-out mice,
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indicating that the antibody used here is speciﬁc for Ap4 (Fig. 6a,
right panel). In mice expressing enhanced green ﬂuorescent
protein (eGFP} from an Lgr5-promoter, Ap4 expression was
detected in eGFP-positive ISCs and TA cells, but not in the
adjacent lysozyme-positive Paneth cells (Supplementary Fig. 5a).
In Ap4-deﬁcient mice, the number of eGFP-positive ISCs was
signiﬁcantly decreased, indicating that Ap4 is necessary for ISC
maintenance (Fig. 6b). Notably, Ap4-deﬁcient mice displayed a
signiﬁcant decrease in the number of ISCs positive for Olfm4
mRNA expression (Fig. 6c). Furthermore, they showed an
increased number of Paneth cells in all regions of the small
intestine (Fig. 6d): in the ileum each crypt section contained ~8
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Paneth cells compared with ~5 Paneth cells in wild-type mice. As
determined by electron microscopy, Paneth cells of Ap4-deﬁcient
mice also displayed an increased number of vesicles, which
contain antimicrobial proteins, such as lysozyme and cryptdin
(Fig. 6e). The length of the small intestine was increased in Ap4-
deﬁcient mice, presumably as a result of widened crypt bases
(Supplementary Fig. 5b). The length of the villi in the ileum was
slightly decreased when compared with wild-type mice (Supple-
mentary Fig. 5b). However, the number of TA cells in small
intestinal crypts (Supplementary Fig. 5b), the length of the colon
and the width of colonic crypts remained unchanged (Supple-
mentary Fig. 5c) The latter presumably due to the absence of
classical Paneth cells in the colon. Ap4 deﬁciency also resulted in
a decreased number of secretory goblet cells in villi of the small
intestine (Supplementary Fig. 5d) and in crypts of the small
intestine and colon (Supplementary Fig. 5e). Accordingly, mRNA
expression of stem cell markers (Smoc2, Lgr5, Olfm4) and the
goblet cell markers (Gob5, Muc2) was signiﬁcantly decreased,
whereas Paneth cell markers (Lysozyme, Cryptdin) were sig-
niﬁcantly increased in the epithelia of the small intestine of Ap4-
deﬁcient mice (Fig. 6f). We did not detect any effect of Ap4
deletion on the rate of apoptosis or proliferation in the small
intestine (Supplementary Fig. 5f, g). Therefore, these processes
did presumably not cause the changes in the numbers of Paneth
cells, goblet cells and ISCs observed in Ap4-deﬁcient mice. In
addition, the effects of Ap4 deletion described here were inde-
pendent of the gender of the mice (Supplementary Fig. 5h, i).
Furthermore, IEC-speciﬁc deletion of Ap4 had the same effects on
the small intestinal and colonic architecture as the germ-line
deletion of Ap4 (Supplementary Fig. 6a-h). Therefore, the effects
of Ap4 loss on ISCs and their derivatives were intestinal epithelial
cell autonomous. Interestingly, Ap4 deﬁciency also decreased the
number of stem cells in the colon (Supplementary Fig. i, j). Age-
matched ApcMin mice deﬁcient for Ap4 also displayed a decreased
number of Lgr5- and Smoc2-positive ISCs per crypt, an increase
in Paneth cells, increased length of the small intestine and
enlargement of the crypt base of normal intestine, without any
change in proliferation or apoptosis in normal epithelium (Sup-
plementary Fig. 7a-g) independent of the gender (Supplementary
Fig. 7h). Notably, ISCs have been shown to efﬁciently form
intestinal tumors upon deletion of Apc24 and play a critical role in
adenoma and cancer cell self-renewal25,26. Taken together, these
results suggest that the decreased rate of tumor formation in Ap4-
deﬁcient ApcMin mice is due to the lower number of functional
ISCs in the intestinal crypts.
Analysis of Ap4 function in intestinal organoids. To further
analyze the functional relevance of Ap4 for ISCs, we generated
small intestinal organoids by ex vivo culture of small intestinal
crypts derived from Villin-Cre-ERT2/Ap4ﬂ/ﬂ mice. After addition
of 4-OHT to established organoids, Ap4 expression was decreased
by ~90% within 3 days, which demonstrates efﬁcient, Cre-
mediated deletion of the ﬂoxed Ap4 allele in these organoids
(Fig. 7a). Upon acute Ap4 inactivation, organoids showed a
pronounced decrease of ISC markers, an increase of Paneth cell
markers, as well as a decrease of goblet cell markers within 3 days
after exposure to 4-OHT, whereas organoids derived from Villin-
Cre-ERT2/Ap4 wild-type mice exposed to 4-OHT did not display
signiﬁcant changes in the expression of these markers (Fig. 7a).
Importantly, Ap4-deﬁcient organoids formed less protrusions
(crypt-like structures), when compared with the Ap4-expressing
organoids (Fig. 7b). As the number of protrusions corresponds to
the number of self-renewing ISCs within organoids27, the
decrease in the number of protrusions in Ap4-deﬁcient organoids
is presumably caused by a decrease in functional ISCs. Taken
together, these results suggest that Ap4 is essential for main-
taining ISCs in their undifferentiated state and plays an important
role in the homeostasis of ISCs and Paneth cells.
Gene expression proﬁling of Ap4-deﬁcient organoids. Next, we
obtained RNA expression proﬁles of Ap4-deﬁcient and Ap4 wild-
type organoids 7 days after 4-OHT treatment using NGS.
Changes in gene expression observed after deletion of Ap4 were
considerably less pronounced in organoids when compared with
adenomas. By setting the cut-off for differential expression to a
fold change > 1.5 (p < 0.05), we identiﬁed 693 mRNAs as differ-
entially regulated as a consequence to deletion of Ap4 (Fig. 7c),
with 319 mRNAs being signiﬁcantly downregulated, and
374 showing upregulation (Fig. 7d). Remarkably, factors involved
in Notch signaling and Wnt/β-catenin signaling were signiﬁcantly
over-represented among the downregulated mRNAs (Supple-
mentary Fig. 8a, Supplementary Data 1). In line with the effect of
Ap4 deletion in adenomas, GSEA indicated that mRNAs char-
acteristic for Lgr5-positive ISCs and several factors involved in
Wnt/β-catenin and Notch signaling pathways were preferentially
downregulated upon deletion of Ap4 (Fig. 8a, b, Supplementary
Fig. 8c, Supplementary Data 2): for example Sox4, Axin2, EphB3
were downregulated (Fig. 8b, Supplementary Data 2). Down-
regulated components of the Notch signaling pathway included
Notch1, and the Notch target gene Hes1, as well as the Notch
activating ligands Dll1, Dll3, Dll4 and Jag2 (Fig. 8b, Supplemen-
tary Data 2). Exemplary conﬁrmations of mRNA down-
regulations of genes important in Wnt/β-catenin signaling and/or
Notch signaling upon acute deletion of Ap4 in intestinal epithelial
cell derived organoids are shown in Fig. 8c. The decreased activity
of the Notch pathway after Ap4 loss was conﬁrmed by immu-
nohistochemical detection of NICD1 in normal crypts in the
small intestine (Supplementary Fig. 8d, e). Not only was the
frequency of NICD1-positive cells per crypt lower, but also the
intensity of the NICD1 signal was decreased, which indicates a
lower activity of the Notch signaling pathway in these cells. Taken
together, these results show that Ap4 contributes to the Wnt/β-
catenin and Notch transcriptional program in normal intestinal
tissue.
Interestingly, the transcription factor Spdef (SAM pointed
domain-containing ETS factor) was downregulated in Ap4-
deﬁcient organoids according to NGS analysis and validated by
qPCR (Fig. 8b, c). Spdef regulates the differentiation and
Fig. 4 Ap4-dependent expression proﬁles in ApcMin/+ adenomas. a GSEA comparing gene expression proﬁles from ApcMin/+/Ap4ﬂ/ﬂ and ApcMin/
+/Ap4ΔIEC adenomas from 120 days old mice with Lgr5-positive stem cell signatures13, Wnt/β-catenin signaling (mSigDB: molecular Signatures Database),
Notch target genes or c-Myc target genes (mSigDB). NES: normalized enrichment score, Nom. p-value: nominal p-value. b Heatmap of selected
differentially expressed mRNAs (p-value < 0.05) from intestinal stem cell gene signatures, Wnt/β-catenin signaling and/or Notch signaling gene
signatures analyzed in a. The heatmap displays relative fold changes in expression levels normalized to the mean expression in the control, ApcMin/
+/Ap4ﬂ/ﬂ, samples for each indicated mRNA. Three biological replicates per genotype were analyzed. c qPCR analysis of the indicated mRNA derived from
tumors from three female mice (ﬁve tumors per mouse) per genotype. d The murine CRC cells CT26 were subjected to qChIP analysis with Ap4 or IgG-
speciﬁc antibodies for ChIP. The mouse acetylcholine receptor (AchR) promoter, which lacks Ap4-binding motifs, served as a negative control. E-boxes used
for qChIP analysis are marked in Supplementary Fig. 3. c, d Results represent the mean ± SD. Results were subjected to an unpaired, two-tailed Student’s t-
test with p-values * < 0.05, ** < 0.01, *** < 0.001, n.s.: not signiﬁcant. See also Supplementary Fig. 3, Supplementary Data 1 and Supplementary Data 2
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maturation of goblet cells28. Downregulation of Spdef may
therefore contribute to the decreased number of goblet cells
observed in Ap4-deﬁcient mice.
As observed in adenomas, c-Myc and E2F target genes were
signiﬁcantly enriched among the downregulated RNAs in AP4-
deﬁcient organoids (Fig. 8a, Supplementary Fig. 8c, Supplemen-
tary Data 2) albeit with rather modest fold changes in expression
that were considerably less pronounced compared with those of
ISC signature and Notch target genes (Supplementary Fig. 8f,
Supplementary Data 2). Interestingly, the differential mRNA
expression caused by deletion of Ap4 was similar in organoids
and adenomas as determined by correlation analysis (Fig. 8d). As
the organoid derived expression proﬁles were obtained in the
absence of non-epithelial cells or stroma, these ﬁndings indicate
that the gene expression changes resulting from the inactivation
of Ap4 are largely epithelial cell autonomous. These results
suggest that the differential regulation of factors involved in Wnt/
β-catenin and/or Notch signaling observed after deletion of Ap4
in ApcMin mice occurs in normal intestinal epithelial stem cells
prior to adenoma development.
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Regulation of the NOTCH pathway by AP4 in human CRC
cells. In order to determine whether the connection between Ap4
and Notch detected here is conserved between species and rele-
vant to human CRCs, we performed expression and functional
analyses in human CRC cell lines. In line with the results
described above, the expression of AP4 and NICD1 proteins
positively correlated in a panel of ﬁve CRC cell lines (Supple-
mentary Fig. 9a). After ectopic AP4 expression in DLD-1 cells,
NOTCH1/NICD1 and the NOTCH-target genes HES1 and
NRARP were induced at the protein and mRNA levels (Supple-
mentary Fig. 9b, c). Downregulation of AP4 by RNA interference
decreased NICD1 protein expression in Colo320 cells (Supple-
mentary Fig. 9d). Furthermore, a NOTCH activity reporter
plasmid was induced by ectopic AP4 expression, but not by a
mutant AP4 protein, which lacks the basic DNA-binding region
(Supplementary Fig. 9e). In addition, analysis of public ChIP-Seq
data showed open and active chromatin surrounding the sites of
AP4 occupancy at the NOTCH1 promoter, because histone
H3K4me1 and H3K27Ac modiﬁcations were increased in their
vicinity (Supplementary Fig. 9f). When we analyzed ChIP-Seq
data, which we had previously obtained after ectopic AP4
expression in the CRC cell line DLD-17, we detected AP4 occu-
pancy at the ASCL2, DLL1, DLL4, EPHB3, HES1, JAG1, JAG2,
NOTCH1, SOX4 and TCF7 promoters in human DLD-1 CRC
cells (Supplementary Fig. 9g). Therefore, AP4 regulates genes
involved in WNT/β-catenin and/or NOTCH signaling directly by
binding to their promoters in CRC cells.
In addition, inhibition of NOTCH signaling by exposure to the
γ-secretase inhibitor Dibenzazepine (DBZ) resulted in a decrease
of AP4 and c-MYC expression in SW620 CRC cells (Supplemen-
tary Fig. 9h). As expected, the NOTCH-target genes NRARP and
HES1 were also repressed. Notably, DBZ suppressed Ap4 protein
expression in the small and large intestine of mice (Supplemen-
tary Fig. 9i). As expected, inhibition of Notch signaling led to an
increase in the number of Paneth cells and goblet cells, as well as
to a decrease of Hes1 and c-Myc expression. As we could not
obtain experimental evidence for a direct regulation of AP4 by
NICD1 (data not shown), the regulation of AP4 by the NOTCH
pathway is presumably mediated by c-MYC, which represents a
known target of the NOTCH pathway29,30. Therefore, AP4, the
NOTCH pathway and c-MYC form a positive feed-back loop.
Role of AP4 in human CRCs. To obtain further evidence for a
clinical relevance of AP4 in CRC initiation and progression, we
analyzed patient-derived expression data that were generated by
the TCGA consortium31. Indeed, AP4 mRNA expression was
signiﬁcantly increased in primary CRCs when compared with
normal mucosa in 41 matched normal versus CRC patient
samples, as well as in unmatched patient samples representing
normal mucosa (n= 41) and primary CRCs (n= 462) (Fig. 9a).
Recently, CRCs were shown to belong to four different molecular
subgroups, the so-called consensus molecular subtypes 1–432. In
line with the results obtained here, CRCs belonging to the
CMS2 subtype, which is characterized by high WNT and c-MYC
activity, showed signiﬁcantly elevated expression of AP4 when
compared with the three other CMS subtypes (Supplementary
Fig. 10a). Moreover, in CRCs from the TCGA cohort AP4
expression showed a positive correlation with the expression of
mRNAs characteristic for Lgr5-positive ISCs14, as well as with
mRNAs encoding factors involved in Wnt/β-catenin signaling
and c-MYC target genes (mSigDB, molecular signature data-
base:33; Fig. 9b). Furthermore, AP4 expression showed a sig-
niﬁcant positive correlation with ASCL2, TCF7, NOTCH1 and
JAG2 expression in 462 primary CRCs in the TCGA cohort
(Fig. 9c). As expected, AP4 expression was also positively asso-
ciated with c-MYC and negatively associated with CDKN1A/p21
expression.
In order to determine whether the positive correlation between
AP4 and NOTCH1/NICD1/HES1 also exists on the level of
protein expression in human CRCs, we determined AP4, NICD1
and HES1 expression levels by immunohistochemical analysis of
220 primary CRC samples. For the evaluation of AP4, NICD1
and HES1 expression, we established a four-stage scoring scheme
(Supplementary Fig. 10b). AP4 expression was highly concordant
with both NICD1 and HES1 expression (Fig. 9d) indicating that
the reciprocal regulation between AP4 and the NOTCH pathway
also occurs in primary, human CRCs.
Discussion
This study identiﬁed Ap4 as an important, rate-limiting mediator
of intestinal adenoma initiation (summarizing model in Fig. 10).
As inactivation of Ap4 led to a decrease in the number of ISCs
and an increase in Paneth cells, it is conceivable that the
decreased formation of adenomas in the absence of Ap4 is due to
the smaller number of bona-ﬁde ISCs that are able to initiate
adenomas after acquiring further genetic and epigenetic altera-
tions. This hypothesis is in accordance with the observation that
tumor-promoting mutations in ISCs are more efﬁcient in gen-
erating tumors than mutations in other, more differentiated
intestinal epithelial cells24,34. In addition, recent analyses have
provided further support for a direct role of stem cell abundance
in the determination of tumor frequencies35: that is, a strong
correlation was found between the tissue-speciﬁc stem cell
number and the risk to develop a tumor for this particular tissue.
Unexpectedly, deletion of Ap4 in intestinal epithelial cells had
no effect on cellular proliferation. In contrast, acute deletion of
Fig. 5 Deletion of Ap4 decreases stemness in adenomas and tumor organoids. a Left panel: in situ hybridization of Lgr5 mRNA. Scale bars represent
100 µm. Right panel: quantiﬁcation of Lgr5-positive area in % in the adenomas from two male and one female mice in at least six adenomas per genotype.
b Left panel: representative pictures of small intestinal tumor organoids 6 days after isolation (passage 0), upper panel, or 4 days after passaging (passage
1), lower panel. Organoids were isolated from three tumors per mouse from two female and two male mice per genotype. Scale bars represent 500 µm.
Right panels: number of tumor organoids per drop of 50 µl Matrigel. A total of 24 drops (passage 0) or 15 drops (passage 1) was analyzed per genotype.
c, d qPCR analysis of the indicated mRNA derived from tumor organoids. e Western blot analysis of the indicated proteins. f Representative pictures of
tumor organoids derived from small intestinal epithelial cells obtained from Lgr5-CreERT2+/-/Apcﬂ/ﬂ and Lgr5-CreERT2+/-/Apcﬂ/ﬂ/Ap4ﬂ/ﬂ mice after
treatment with 4-OHT. After isolation, organoids were kept in ENR media (contains EGF, Noggin and RSPO1). Forty-eight hours after isolation, organoids
were treated with 4-OHT in a concentration of 100 nM for 48 h to delete Apc or Apc in addition to Ap4 in Lgr5-positive intestinal stem cells (ISC).
Additional 48 h later, organoids were passaged and EN media (containing EGF and Noggin, but without RSPO1) was used, which selectively allowed Apc-
deﬁcient tumoroids to expand (passage 1). Pictures were taken 7 days after passaging in case of passage 1, and 6 days after passaging in case of passage 5.
gMean tumor organoid number per drop of 25 µl Matrigel calculated as a mean of a total of 20 drops of 25 µl Matrigel each for passage 1, 3–5 or a total of
11 drops (Ap4 wt) and 6 drops (Ap4 ko) for passage 2. h Mean tumor organoid size was measured and calculated from Matrigel drops as depicted
exemplarily in d. a, b, c, d, g, h Results represent the mean ± SD. Results were subjected to an unpaired, two-tailed Student’s t-test with p-values * < 0.05,
** < 0.01, *** < 0.001, n.s.: not signiﬁcant. See also Supplementary Fig. 4
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Fig. 6 Inactivation of Ap4 causes decrease of ISC and increase Paneth cell numbers. a Immunohistochemical detection of Ap4 (brown) in small intestinal
tissue, ileum of one male and one female mouse per genotype. Scale bar= 50 µm (25 µm insert), white arrow: site of speciﬁc Ap4 expression. Mast cells in
the villi display an unspeciﬁc staining. Counterstaining with hematoxylin. b Left panel: immunohistochemical analyses of Lgr5-eGFP in intestinal sections of
63 days old Lgr5-eGFP mice. Scale bars represent 25 µm. Right panel: quantiﬁcation of Lgr5-eGFP-positive cells in the crypt base of the ileum from two
male and two female mice (130 crypts) per genotype. c Left panel: in situ hybridization of Olfm4 mRNA. Scale bars represent 25 µm. Right panel:
quantiﬁcation of Olfm4-positive cells in the crypt base from two male and two female mice (316 crypts) per genotype. d Left: immunohistochemical
detection of Lysozyme (brown) expressed in Paneth cells. Counterstaining with hematoxylin. Scale bar: 50 µm (25 µm insert). Right: the small intestine/
ileum from two male and two female mice (100 crypts) per genotype was analyzed for Paneth cells/crypt. e Electron microscopic analysis of small
intestinal crypt base; white arrow: Paneth cells. Scale bar: 25 µm. f qPCR analysis of the indicated mRNAs in IECs of the ileum of two male and one female
mice per genotype. b, c, d, e, f Results represent the mean ± SD. Results were subjected to an unpaired, two-tailed Student’s t-test with p-values * < 0.05,
** < 0.01, *** < 0.001, n.s.: not signiﬁcant. See also Supplementary Figs. 5, 6, 7
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06001-x
10 NATURE COMMUNICATIONS |  (2018) 9:3573 | DOI: 10.1038/s41467-018-06001-x | www.nature.com/naturecommunications
c-Myc using Ah-Cre or Villin-CreER alleles in post-natal IECs
resulted in defects in proliferation and biosynthetic activity in the
small intestine36,37. The different result may be due to the dif-
ferent timing of gene inactivation: here we used either germ-line
or Villin-Cre-mediated deletion of Ap4, whereas the two studies
on c-Myc employed deletion at least 7 days after birth and later,
which was necessary because c-Myc is essential during embry-
ogenesis. However, they observed that IEC proliferation was at
least in part independent of c-Myc. Therefore, IECs may rely on
alternative pathways for promoting cell proliferation. In addition,
these differences indicate that Ap4 is responsible for mediating a
distinct aspect of c-Myc function and does not simply perform all
functions of c-Myc.
The results obtained in tumoroids derived from ApcMin mice
and in tumoroids generated by acute deletion of Apc imply that
Ap4 is important for the initiation but not required for the
maintenance of tumoroids. These results are in line with the
observations we made in ApcMin mice, where Ap4 loss decreased
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Fig. 7 Effects of Ap4 deletion on intestinal organoids. a qPCR analysis of the indicated mRNA from organoids isolated from three female mice per genotype
after passaging and 7 days after Cre activation by 4-OHT. b Left panel: representative pictures of small intestinal organoids 7 days after passaging and Cre
activation by 4-OHT. Scale bars represent 20 µm. Right panel: quantiﬁcation of protrusions (crypt-like structures) per organoid derived from three female
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p < 0.05) in Ap4ﬂ/ﬂ and Ap4ΔIEC organoids as determined by edgeR and DESeq2. d Volcano plot and heatmap depicting expression changes of differentially
expressed mRNAs between Vil-Cre-ERT2 and Vil-Cre-ERT2/Ap4ﬂ/ﬂ organoids, 7 days after Cre activation by 4-OHT, detected by RNA-Seq. Left panel:
volcano plot depicting expression changes of differentially expressed mRNAs (fold change≥ 1.5) from Ap4ﬂ/ﬂ and Ap4ΔIEC organoids. Downregulated
mRNAs are depicted in blue, upregulated mRNAs are depicted in red. RNAs with fold changes < 1.5 and/or statistically nonsigniﬁcant changes in
expression are indicated in black. Dashed vertical lines indicate 1.5-fold change cutoff. Dashed horizontal line indicates the cutoff for adjusted p-values <
0.05 as determined with DESeq2. Right panel: Heatmap depicting expression changes of differentially expressed mRNAs (fold change≥ 1.5 p < 0.05 as
determined by edgeR and DESeq2) from Ap4ﬂ/ﬂ and Ap4ΔIEC organoids. Colors indicate relative expression values from minimum (blue) to maximum (red)
for each RNA sample per differentially regulated mRNA. a, b Results represent the mean ± SD. Results were subjected to an unpaired, two-tailed Student’s
t-test with p-values * < 0.05, ** < 0.01, *** < 0.001, n.s.: not signiﬁcant
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the number of adenomas but not their growth/size. Interestingly,
Lgr5 gene expression has been reported previously to be dis-
pensable for ex vivo tumor organoid maintenance38.
Notably, the deletion of Ap4 resulted in decreased expression of
Notch pathway components including Notch1 itself. Interest-
ingly, Notch pathway inactivation promotes differentiation of
ISCs into Paneth cells21, leading to Paneth cell hyperplasia and a
decrease in ISCs21,39. However, the number of goblet cells
increases after Notch inhibition, whereas it decreased after Ap4
inactivation in our study. Therefore, Ap4 loss does not simply
recapitulate inhibition of the Notch pathway suggesting that Ap4
regulates additional pathways/genes, which contribute to the
differentiation of goblet cells. For example, Ap4 deﬁciency
resulted in a decrease in expression of the transcription factor
Spdef. Interestingly, it was previously shown that ectopic
expression of Spdef in the murine intestine promotes the
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differentiation of goblet cells, whereas it decreased the number of
Paneth cells28. Accordingly, the decrease of Spdef observed in
Ap4-deﬁcient organoids could potentially also contribute to the
decreased number of goblet cells detected after Ap4 deletion.
Alternatively, the decrease in goblet cells may have been a com-
pensatory response to the increase in Paneth cells caused by Ap4
deletion.
As activation of Notch signaling promotes the initiation of
murine intestinal adenomas40 and inhibition of Notch signaling
leads to mitotic arrest and apoptosis in human colon cancer
cells41, the Notch pathway may represent a route via which Ap4
promotes intestinal adenoma initiation. Conversely, Ap4 deletion
may prevent adenoma initiation via inhibiting the Notch pathway.
By studying human CRC cell lines, we had previously found
that ectopic Ap4 expression is sufﬁcient to activate the Wnt
pathway. Our NGS analysis presented here further supports these
ﬁndings with in vivo evidence, because numerous components of
the Wnt/β-catenin signaling pathway were downregulated in
Ap4-deﬁcient adenomas and derived organoids. In support of this
conjecture, a comprehensive study has recently shown that Ap4 is
an important component of Wnt signaling during X. laevis
development and acts down-stream of the β-catenin destruction
complex to regulate expression of Wnt/β-catenin target genes42.
Therefore, Ap4 presumably represents an integral component of
the Wnt pathway and its activities during development and
tumorigenesis. The downregulation of genes involved in Wnt
signaling observed here may critically contribute to the decreased
number of ISCs observed in Ap4-deﬁcient mice, because the Wnt
pathway has been implicated in the maintenance of stemness and
suppression of differentiation in ISCs43–45.
It is well known that a controlled balance of the Notch and
Wnt pathway activity is important for the homeostasis of stem
cells and cell fate decisions in the intestine and that these two
pathways regulate each other at multiple points46. Speciﬁcally,
inhibition of NOTCH1/2 receptors was shown to induce Wnt
signaling, which then promoted goblet cell differentiation46. The
decrease of Wnt pathway component expression after AP4 dele-
tion may therefore alter the expected outcome of a Notch inhi-
bition (i.e., increase of all secretory cell numbers) unto the
decrease of goblet cell differentiation observed here.
The increased number of Paneth cells in Ap4-deﬁcient mice
might result from an increased propensity of Ap4-deﬁcient ISCs
to generate Paneth cell precursors during asymmetric stem cell
division. Interestingly, Lgr5 represents an Ap4 target gene7 and
Lgr5 deﬁciency promotes Paneth cell differentiation in mice47.
Further discussions of the results and the potential limitations
of the ApcMin mouse model can be found in the Supplementary
Discussion.
In conclusion, our study demonstrates an unexpected, central
role of Ap4 in ISCs and Paneth cell homeostasis and revealed that
Ap4 function is critical for adenoma initiation in a preclinical
model of inherited colon cancer. Besides illuminating an impor-
tant aspect of CRC biology, our results indicate that Ap4 repre-
sents a candidate therapeutic target for the treatment of CRCs.
Methods
Generation and husbandry of mice. Targeted ES cells with C57BL/6N back-
ground were obtained by homologous recombination with a vector containing the
Ap4 exons 2–4 ﬂanked by loxP sites and an intronic neomycin resistance (Neo)
cassette ﬂanked by frt sites (scheme in Jackstadt et al.6). Ap4ﬂ/ﬂ mice were gen-
erated by injection of targeted ES cells into C57BL/6N blastocyst. The Neo cassette
was removed by crossing to ﬂp-mice48 and germ-line Ap4 knock-out mice were
generated by crossing with CMV-Cre+/− mice49. Ap4-/- mice showed no overt
phenotype and were born at normal Mendelian ratio. Oligonucleotides used for
genotyping are listed in Supplementary Table S1. For analysis of the effect of Ap4
inactivation on the ISC number, we used Lgr5-eGFP-Cre-ERT2+/− mice50
(obtained from Hans Clevers, University Medical Center Utrecht, The Nether-
lands) and for speciﬁc deletion of Ap4 in intestinal epithelial cells or derived
organoids, we used Villin-Cre+/− or Villin-Cre-ERT2+/− mice (obtained from
Klaus-Peter Janssen, Technical University Munich, Germany), respectively51.
APCMin/+ mice9,10 were used to analyze the role of Ap4 in intestinal adenoma
development (obtained from Marlon Schneider, Ludwig-Maximilians-Universität,
München, Germany). Mice were kept in individually ventilated cages with a 12-h
light/dark cycle and ad libitum access to water and standard rodent diet. For
determination of proliferation rates, 75 mg/kg BrdU (Amersham) in phosphate-
buffered saline (PBS) was intraperitoneally injected 1.5 h before mice were sacri-
ﬁced. All animal experimentations and analyses were approved by the Government
of Upper Bavaria, Germany (AZ 55.2-1-54-2532-4-2014).
Tissue preparation and adenoma counting. After isolation of intestinal tissue,
the colon and small intestine were separated and ﬂushed with PBS to remove stool.
The small intestine was dissected into duodenum, jejenum and ileum. The colon
and small intestine were opened longitudinally and rolled with the mucosa oriented
outwards and ﬁxed in formalin, dehydrated and embedded into parafﬁn. For
evaluation of tumor numbers, each part of the intestine was cut longitudinally and
spread on Whatman 3 MM paper. After ﬁxation in formalin, adenomas were
counted under a dissection microscope (Zeiss) with 10× magniﬁcation.
Hematoxylin and eosin (HE) and PAS/Alcian blue staining. Formalin-ﬁxed,
parafﬁn-embedded (FFPE) tissue was cut into 2 µm sections on a rotating
microtome (Microm HM355S, Thermo Scientiﬁc). The slides were de-parafﬁnized
and stained with hematoxylin (Waldeck) for 6 min followed by eosin (Sigma-
Aldrich) for 2.5 min in an automated slide staining device (Tissue-Tek, Prisma).
Periodic acid-Schiff (PAS) staining was done by applying Alcian blue pH 1 (Bio
Optica) for 10 min followed by periodic acid (Merck) for 5 min, Schiff’s reagent
(Sigma-Aldrich) for 5 min and counterstaining with hematoxylin (Waldeck).
Immunohistochemistry. FFPE tissue was cut into 2 µm sections on a microtome
and de-parafﬁnized. After antigen retrieval, slides were incubated with primary
antibody (the primary antibodies used are listed in Supplementary Table 4) for
1 h at room temperature and washed with TRIS-HCL buffer (pH 7.5) followed by
a secondary antibody. Antibodies were detected with the ABC kit using DAB
(Vector and Dako) for brown stainings or AEC (Thermo Fisher Scientiﬁc) for red
stainings. The slides were counterstained with hematoxylin (Vector) and
mounted with Roti®-Histokitt II (Roth). All stainings were performed with the
respective IgG control (Supplementary Table 4) as a negative control and without
primary antibody as a system control. Images were captured on an Axioplan2
imaging microscope (Zeiss) equipped with an AxioCamHRc Camera (Zeiss). For
analysis of cleaved caspase-3, the AxioVision Software (Zeiss) was used to
measure the area for each tumor in mm2.
Fig. 8 NGS analysis of intestinal organoids after deletion of Ap4. a GSEA comparing gene expression proﬁles from Vil-Cre-ERT2 and Vil-Cre-ERT2/Ap4ﬂ/ﬂ
organoids 7 days after Cre activation by 4-OHT with Lgr5-positive stem cell signatures13, β-catenin regulated/ISC-speciﬁc genes60, Notch targets genes61
or c-Myc target genes (mSigDB: molecular Signatures Database). NES: normalized enrichment score, Nom. p-value: nominal p-value. b Heatmap depicting
expression changes of selected differentially expressed mRNAs (p-value < 0.05) from stem cell gene signatures, Wnt signaling and/or Notch signaling
gene signatures analyzed in a. The heatmap displays relative expression levels normalized to the mean expression in the control (Vil-CreERT2) samples for
each mRNA. Three biological replicates per genotype were analyzed. c qPCR analysis of the indicated mRNA of organoids with the indicated genotypes
3 days and 7 days after 4-OHT induction. d Scatter plot displaying the correlation of expression changes of the 424 mRNAs signiﬁcantly (p < 0.05)
downregulated in both adenomas and organoids (shown in gray).The mRNAs from stem cell gene signatures, Notch target gene signatures and c-Myc
target genes analyzed in Figs. 4a and 8a in both adenomas and organoids are highlighted with the indicated colors. The Pearson correlation coefﬁcient of all
424 mRNAs downregulated in both adenomas and organoids and statistical signiﬁcance are indicated. c Results represent the mean ± SD. Results were
subjected to an unpaired, two-tailed Student’s t-test with p-values * < 0.05, ** < 0.01, *** < 0.001, n.s.: not signiﬁcant. See also Supplementary Fig. 9,
Supplementary Data 1 and Supplementary Data 2
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In situ hybridization. For detection of ISCs with an Olfm4 mRNA probe, the
Bluescript II plasmid p695-pBS-mOlfm4 (kindly provided by Prof. Hans Clevers)
was linearized by using a NotI restriction enzyme. The pCMV6 entry plasmids
containing the Lgr5 or Smoc2 open reading frame (ORF) were obtained from
Origene with the catalog number MR219702 or MR207121, respectively. Both
ORFs were cloned into the pBSII KS plasmid by using the restriction enzymes NotI
and KpnI. The pBSII KS-mSmoc2 was linearized with the KpnI restriction enzyme
and the pBSII KS-mLgr5 was linearized with the BclI restriction enzyme. The
Olfm4, Lgr5 and Smoc2 RNA probe has was generated by an in vitro transcription
reaction with a RNA-T7 Polymerase by using the DIG Northern Starter Kit (Roche
Diagnostics). During the transcription reaction, the probe was labeled with
digoxigenin (DIG). The in situ hybridization was performed on freshly prepared
8 µm parafﬁn sections as described52.
Isolation of IECs. Each part of the intestine was dissected longitudinally and cut
into small pieces. IECs were isolated by shaking the tissue in Hanks' Balanced Salt
solution/ethylene-diamine-tetra-acetic acid (HBSS/EDTA) at 37 °C for 10 min. The
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supernatant including IECs was centrifuged and the pellet was washed with ice-
cold PBS, frozen in liquid nitrogen and stored at −80 °C until RNA isolation.
Crypt isolation and organoid culture. Crypt isolation and organoid culture was
performed as described before53. The small intestine was opened longitudinally and
the villi were scraped off under a dissection microscope by using a surgical blade.
The intestine was cut into small pieces and incubated in 8 mM EDTA in HBSS for
5 min to remove the rest of the villi followed by an additional incubation in EDTA
for 30 min at 4 °C. Isolated crypts were washed in advanced Dulbecco’s modiﬁed
Eagle’s medium (DMEM)/F12 (Gibco Life Technologies) containing Glutamax
(Gibco Life Technologies) and Hepes (Gibco Life Technologies), passed through a
100 µm cell strainer and either frozen in liquid nitrogen (IEC) or counted and
pelleted for culturing. For each well in a 24-well plate, 200 crypts were mixed with
50 µl of growth factor reduced, Phenol red-free Matrigel (Corning). After poly-
merization of the Matrigel, 600 µl of crypt culture medium was added. Crypt
culture medium consists of advanced DMEM/F12 supplemented with 1:100
penicillin/streptomycin (Gibco Life Technologies), 1:100 Hepes, 1:100 Glutamax
and the following growth factors: 100 ng/ml Noggin (Preprotech), 1:100 N2 (Gibco
Life Technologies), 1:50 B27 retinoic acid free (Gibco Life Technologies), 50 ng/ml
EGF (Preprotech), 500 ng/ml RSPO1 (Sinobiological), 10 µM Y-27632 (MedBio-
chem Express) was added only the ﬁrst 2 days after isolation/culturing or passaging
to avoid anoikis, and 100 ng/ml Wnt-3a (Abcam) was added only the ﬁrst 2 days
after isolation/culturing. Crypt culture medium was changed every 2 days. Once a
week, organoids were passaged at a 1:6 ratio. For passaging, organoids were
removed from Matrigel and dissociated mechanically into single-crypt domains
before they were transferred into fresh Matrigel. 4-OHT (Sigma-Aldrich), diluted
in ethanol, was added to the crypt culture medium to a ﬁnal concentration of
500 nM for at least 12 h. As a control, the same volume of ethanol without 4-OHT
was added to the crypt culture medium. RNA was isolated using Trizol (Invitrogen)
and the RNeasy Mini Kit (Qiagen).
For generation of tumoroids, intestinal adenoma cells from three tumors for
each ApcMin/+ mouse were isolated by lysis in DMEM containing 4000 units
Collagenase Type IV (Merck Millipore) and 125 µg/ml Dispase Type II (Sigma-
Aldrich). Single cells were embedded in Matrigel and seeded in 24-well plates
(15,000 single cells per 50 μl Matrigel per well). The tumor organoid culture
medium was formulated as described before38. Crypt culture medium (advanced
DMEM/F12 supplemented with 1:100 penicillin/streptomycin, 1:100 Hepes and
1:100 Glutamax and growth factors (1:100 N2, 1:50 B27, 50 ng/ml EGF). In all,
10 µM Y-27632 was added only the ﬁrst 2 days after isolation/culturing or
passaging to avoid anoikis. Counting of the number of organoids per well (six wells
per mouse) was performed 6 days after isolation before the ﬁrst passaging.
Passaging was performed as described above for normal organoids. RNA was
isolated using Trizol and the RNeasy Mini Kit. For western blot analysis, tumor
organoids were lysed in RIPA lysis buffer (50 mM Tris/HCl, pH 8.0, 250 mM NaCl,
1% NP40, 0.5% (w/v) sodium deoxycholate, 0.1% sodium dodecylsulfate, Complete
Mini protease inhibitors (Roche Diagnostics)).
For tumoroid formation after acute loss of Apc or Apc and Ap4, crypts were
isolated as described above. For each well in a six-well plate, approximately eight
drops of 25 µl Matrigel and 50 crypts each were plated and overlaid with ENR
media (containing EGF, Noggin and RSPO1) as described above. Forty-eight hours
after isolation, organoids were treated with 100 nM 4-OHT in ENR media for 48 h.
After passaging an additional 48 h, the culture conditions were switched to EN
devoid of RSPO1 to select for tumoroid growth. Pictures of tumoroids were taken
with a Nikon AZ-100 macroscope.
Tissue microarrays and IHC analysis of clinical samples. Colon cancer speci-
mens from patients that underwent surgical resection at the University of Munich
(LMU) were drawn from the archives of the Institute of Pathology. Specimens were
anonymized, and the need for consent was waived by the institutional ethics
committee of the Medical Faculty of the LMU. Tissue microarray (TMAs) with
Fig. 9 Ap4 mRNA expression and associations in human CRCs deposited at TCGA and its correlative analysis of AP4, NICD1 and HES1 protein expression
in human CRCs. a Ap4 RNA expression levels from matched patient samples from normal mucosa and tumor tissue (left), or unmatched normal mucosa
and tumor tissues (right). RNA expression data were obtained from publically available TCGA colorectal adenocarcinoma (COAD) datasets31. Left panel:
matched samples, 41 normal mucosa and 41 tumor tissue samples. Right panel: 41 normal mucosa samples and 462 tumor tissue samples were used.
b Expression of human homologs of the Lgr5-positive stem cell signature14, members of the HALLMARKWnt signaling gene set33 or c-Myc target genes33
are strongly linked with Ap4 expression in human tumors. All genes within the TCGA datasets from human colorectal tumors were pre-ranked by
expression correlation coefﬁcient (Pearson r) with Ap4 in descending order from left (positive correlation) to right (negative correlation) and analyzed by
GSEA. c Scatter plots displaying pairwise comparisons of mRNA expression levels [RSEM] of the indicated genes for 462 TCGA COAD samples. The
correlation coefﬁcients and p-values of Pearson´s and Spearman's correlations, as well as the linear regression trend line are indicated. d Left: dot plots
displaying pairwise comparisons of IHC staining scores (see Supplementary Fig. 10b for more information) for AP4, NICD and HES1 from 220 human CRC
tumor microarray (TMA) samples. Dot sizes represent tumor sample numbers. Right: Heatmap displaying Pearson r correlation coefﬁcients of IHC scores
obtained from 220 tumor samples stained for AP4, NICD1 and HES1 expression. a Left panel: results were subjected to a paired, two-tailed Student’s t-test
with p-values * < 0.05, ** < 0.01, *** < 0.001. a Right panel and b results represent the mean ± SD. Results were subjected to an unpaired, two-tailed
Student’s t-test with p-values * < 0.05, ** < 0.01, *** < 0.001, n.s.: not signiﬁcant. See also Supplementary Fig. 10
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Fig. 10 Model summarizing the results of this study. The results are
explained in the context of the previously described biology of the intestinal
crypt: The homeostasis of the intestinal epithelium is regulated by the
Wnt/β-catenin and Notch pathways, which control stem cell maintenance
and differentiation16,17. In the small intestine, the crypt base harbors 4–6
intestinal stem cells (ISCs), which are surrounded by supporting Paneth
cells. The Lgr5-positive ISCs divide asymmetrically to self-renew and to
generate highly proliferative, Lgr5-negative transit-amplifying (TA) cells,
which differentiate into absorptive enterocytes or secretory cells, such as
goblet, tuft and entero-endocrine cells16–18,63. Paneth cells are derived from
Lgr5-positive precursors generated by asymmetric division of ISCs, which
proliferate slowly and therefore represent label-retaining cells (LRCs)64. In
the present study, we found that deletion of Ap4 decreased the number of
ISCs and increased the number of Paneth cells. Furthermore, we found that
the Wnt and Notch pathways were downregulated in the absence of Ap4.
The decreased number of ISC presumably resulted in the decreased
number of adenomas in Ap4-deﬁcient APCMin/+ mice, since Lgr5-positive
ISCs were shown to represent the cells of origin for intestinal cancer24,34
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samples of 225 (220 evaluable) stage II primary CRC cases were generated with six
representative 1 mm cores of each case. In all, 5 µm TMA sections were de-
parafﬁnized and stained with primary antibodies (listed in Supplementary Table 4)
on a Ventana Benchmark XT Autostainer with UltraView Universal DAB and
alkaline phosphatase detection kits (Ventana Medical Systems). The stainings were
evaluated according to the score shown in Supplementary Fig. 10B.
RNA expression proﬁling by RNA-Seq. Total RNA from organoids or adenomas
was used for RNA-Seq. Random primed complementary DNA libraries were
constructed and sequenced using the HiSeq2500 (Illumina) platform by GATC
(Konstanz, Germany). Each sample was covered by at least 30 million single reads
of 50-bp length.
Bioinformatics analyses of RNA-Seq and ChIP-Seq data. RNA-Seq FASTQ ﬁles
were processed using the RNA-Seq module implemented in the CLC Genomics
Workbench v8.0 software (Qiagen Bioinformatics) with default settings and were
mapped to the GRCm38/mm10 mouse reference genome and its associated gene
and transcript annotation (EMSEMBL). RNA-Seq data were ﬁltered to exclude
weakly expressed transcripts with less than ﬁve mapped exon reads in all samples
from the analysis and subjected to upper quartile normalization using the R/
Bioconductor RUVSeq (remove unwanted variation from RNA-Seq data) package
as described in Risso et al.54. Differential gene expression analysis was performed
with edgeR55,56 or DESeq257 after further normalization using the RUVg approach
to remove variation between RNA samples resulting from differences in library
preparation. GSEA was performed using the GSEA software58,59. Lgr5+ or
EphB2high stem cell gene sets were obtained from refs.13–15. The Wnt/β-catenin
target gene sets were obtained from Fevr et al.60. The Notch target gene set was
obtained from Li et al.61. Additional gene sets representing genes involved in Wnt/
β-catenin signaling, EMT or c-Myc target genes were obtained from the Molecular
Signatures database (MSigDB)33. Enrichment of Hallmark gene sets or Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways among differentially
regulated genes was analyzed with the Molecular Signatures database program
(MSigDB)33. Heatmaps were generated with GENE-E (Broad Institute).
ChIP-Seq data of genome-wide Ap4 occupancy in murine B and T cells (GEO
accession nos. GSE80669 and GSE58075) and human CRC cells (GEO accession
no. GSE46935) were obtained from previously published studies7,22,23 and were
analyzed with the UCSC genome browser62.
In silico analysis of human colorectal patient samples. Normalized RNA
expression (RNA-Seq by expectation maximization (RSEM)) data from CRC
patient samples were obtained from the publically available TCGA datasets31 at
https://cancergenome.nih.gov/. Association of TCGA patient samples with the
different CMS categories was obtained from the Cancer Subtyping Consortium
(CRCSC) at www.synapse.org. The CMS subtypes were described in Guinney
et al.32.
Statistical analysis. The Graph Pad Prism software was used for statistical ana-
lyses. A Student’s t-test (unpaired, two-tailed) was used for calculation of sig-
niﬁcant differences between two groups of samples or mice, with p < 0.05
considered signiﬁcant. Asterisks generally indicate: *p < 0.05, **p < 0.01 and ***p <
0.001, n.s.= not signiﬁcant. For calculation of correlation coefﬁcients, Pearson's or
Spearman's correlation analyses were applied. Kaplan–Meier curves were analyzed
by log-rank (Mantel–Cox) test.
Data availability
RNA-Seq data that support the ﬁndings of this study have been deposited in Gene
Expression Omnibus (GEO) with the accession codes “GSE99434” and “GSE99437”. All
other data are available from the corresponding author on reasonable request.
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